ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,661Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 1107

$1.15M Total Retail Price of All Prescriptions

Rank: 65 out of 1107

834 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 834 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 834 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 16,524 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,063 696 S3 1 1
OMEPRAZOLE 613 375 2 4
LEVOTHYROXINE SODIUM 606 414 3 3
SIMVASTATIN 559 408 4 5
FUROSEMIDE 540 407 5 7
METFORMIN HCL 523 350 6 8
AMLODIPINE BESYLATE 478 443 7 6
LISINOPRIL 466 357 8 2
HYDROCHLOROTHIAZIDE 391 314 9 11
ENALAPRIL MALEATE 356 227 10 98
CITALOPRAM HBR 350 271 11 17
POTASSIUM CHLORIDE 307 228 12 14
SERTRALINE HCL 295 207 13 20
PRAVASTATIN SODIUM 284 236 14 12
WARFARIN SODIUM 280 254 15 15
GABAPENTIN 265 179 16 9
METOPROLOL TARTRATE 242 198 17 10
PANTOPRAZOLE SODIUM 231 152 18 30
RISPERIDONE 227 216 19 79
TRAZODONE HCL 226 171 20 33
ZOLPIDEM TARTRATE 219 171 21 22
ATENOLOL 200 180 22 19
RANITIDINE HCL 183 97 23 21
DONEPEZIL HCL 177 161 24 32
CLOPIDOGREL 175 146 25 28
NAMENDA 169 155 26 42
ATORVASTATIN CALCIUM 168 136 27 13
FLUOXETINE HCL 164 69 28 47
METFORMIN HCL ER 164 136 28 58
PROMETHAZINE HCL 164 85 R 28 44
METOPROLOL SUCCINATE 162 144 31 16
LOSARTAN POTASSIUM 154 136 32 29
AZITHROMYCIN 154 102 32 35
NEXIUM 152 110 34 18
ALPRAZOLAM 152 101 34 87
LOVASTATIN 150 132 36 55
PAROXETINE HCL 147 124 37 45
PROAIR HFA 145 88 38 37
DIOVAN 141 117 39 51
FENTANYL 140 105 S2 40 105
ALENDRONATE SODIUM 137 121 41 41
LANTUS 133 85 42 49
POLYETHYLENE GLYCOL 3350 133 116 42 46
CARVEDILOL 133 123 42 27
NAPROXEN 132 59 45 80
BACLOFEN 130 65 46 133
CIPROFLOXACIN HCL 124 107 47 59
PLAVIX 124 106 47 39
CYCLOBENZAPRINE HCL 122 50 R 49 56
NYSTATIN 120 75 50 110
ESTRADIOL 116 63 R 51 151
CYMBALTA 113 78 52 50
DIGOXIN 112 112 53 52
ALLOPURINOL 111 97 54 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 93 55 24
MELOXICAM 104 87 56 25
MIRTAZAPINE 104 90 56 61
PREMARIN 103 68 R 58 149
OXYCODONE HCL-ACETAMINOPHEN 103 47 S2 58 93
TRAMADOL HCL 102 71 60 26
LOSARTAN-HYDROCHLOROTHIAZIDE 100 94 61 66
ALBUTEROL SULFATE 99 95 62 144
ESCITALOPRAM OXALATE 98 79 63 82
PERMETHRIN 94 87 64 402
KLOR-CON M20 94 79 64 75
CELEBREX 94 57 64 85
LACTULOSE 93 79 67 89
LEVOFLOXACIN 93 79 67 71
MECLIZINE HCL 92 92 69 114
AMITRIPTYLINE HCL 92 66 R 69 48
ADVAIR DISKUS 90 72 71 54
TAMSULOSIN HCL 88 87 72 30
TRIAMTERENE-HCTZ 87 69 73 62
CLONIDINE HCL 87 57 73 53
GLIPIZIDE 85 63 75 64
CARBAMAZEPINE 84 33 76 215
GLIPIZIDE ER 82 66 77 115
IBUPROFEN 81 46 78 63
SYNTHROID 81 45 78 70
VENTOLIN HFA 80 41 80 97
DIOVAN HCT 79 58 81 106
METHYLPREDNISOLONE 77 51 82 119
NIFEDIPINE ER 74 63 83 168
FLUTICASONE PROPIONATE 74 66 83 38
ENDOCET 74 44 S2 83 91
AMOXICILLIN 71 53 86 90
SPIRIVA 68 42 87 57
SUCRALFATE 68 29 87 121
CRESTOR 68 35 87 23
SINGULAIR 67 63 90 65
DIVALPROEX SODIUM 66 32 91 96
PREDNISONE 63 59 92 40
DIVALPROEX SODIUM ER 63 28 92 216
VERAPAMIL ER 63 41 92 113
OXYBUTYNIN CHLORIDE ER 62 17 95 179
SPIRONOLACTONE 61 57 96 72
HALOPERIDOL 60 60 97 225
ISOSORBIDE MONONITRATE ER 60 49 97 34
ROPINIROLE HCL 59 59 99 69
CEPHALEXIN 59 42 99 81
VESICARE 58 32 101 228
EVISTA 58 51 101 135
GLYBURIDE 57 50 R 103 68
MORPHINE SULFATE ER 57 24 S2 103 156
CAPTOPRIL 55 39 105 296
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 37 106 88
FLUCONAZOLE 54 29 106 150
BENAZEPRIL HCL 54 54 106 86
QUETIAPINE FUMARATE 53 38 109 94
OXYCODONE-ACETAMINOPHEN 52 39 S2 110 104
METOCLOPRAMIDE HCL 51 0 111 116
NITROGLYCERIN PATCH 50 50 112 184
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.